Robert Michael Floyd
Chief Operating Officer, Processa Pharmaceuticals, Inc.
Companies
- Processa Pharmaceuticals, Inc.Chief operating officer Oct 16, 2020 to Feb 10, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Processa Pharmaceuticals, Inc. PCSA172,061 shares2$289.1K at $1.68Feb 10, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 9, 2023Granted 10,000 shares at $0.80 of Processa Pharmaceuticals, Inc.2
- Oct 6, 2022Shares withheld for tax 4,163 shares of Processa Pharmaceuticals, Inc.3
- Oct 6, 2022Exercised options 12,500 shares of Processa Pharmaceuticals, Inc.3
- Aug 16, 2022Gift 7,000 shares of Processa Pharmaceuticals, Inc.4
- Mar 31, 2022Gift 7,000 shares of Processa Pharmaceuticals, Inc.5
- Oct 6, 2021Shares withheld for tax 4,663 shares of Processa Pharmaceuticals, Inc.6
- Oct 6, 2021Exercised options 12,500 shares of Processa Pharmaceuticals, Inc.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Oct 11, 2022
- 4SEC EDGARForm 4 filed Aug 23, 2022
- 5SEC EDGARForm 4 filed Apr 4, 2022
- 6SEC EDGARForm 4 filed Oct 8, 2021